Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398989 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin
A Phase 4 study of Photo-aged Skin and Crepey Skin, sponsored by Galderma R&D.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT07398989 is a Phase 4 study of Photo-aged Skin and Crepey Skin that is actively recruiting participants, run by Galderma R&D. The registered enrollment target is 30 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07398989, a Phase 4 study of Photo-aged Skin and Crepey Skin, is actively recruiting participants, sponsored by Galderma R&D.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
Subjects having mild-to-moderate crepiness, photodamage, and loss of firmness will apply a topical skincare regimen to the knees, thighs, hands, and all over the body. Evaluations of the regimen's efficacy will be conducted at 4 weeks, 8 weeks, and 12 weeks post-baseline.
Conditions Studied
Interventions
- DRUG Cetaphil
Study Locations (2)
California
- Ablon Skin Institute & Research Center - Manhattan Beach
South Carolina
- Clinical Research Center of the Carolinas - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-12 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07398989
The ClinicalTrials.gov registry entry for NCT07398989 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Photo-aged Skin appearing as the primary indexed condition, and to 1 intervention - of which Cetaphil is the first listed.
NCT07398989 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, South Carolina.
Frequently Asked Questions
What is clinical trial NCT07398989 about?
NCT07398989 is a clinical study titled "A Clinical Study to Assess Efficacy and Tolerability of a Topical Skincare Product on Adults With Mature, Crepey Skin". Subjects having mild-to-moderate crepiness, photodamage, and loss of firmness will apply a topical skincare regimen to the knees, thighs, hands, and all over the body. Evaluations of the regimen's efficacy will be conducted at 4 weeks, 8 weeks, and 12 weeks post-baseline.
What is the current status of trial NCT07398989?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-08-12. Estimated completion is 2026-03.
What conditions does trial NCT07398989 study?
This clinical trial studies the following conditions: Photo-aged Skin, Crepey Skin, Aging Skin.
What interventions are being tested in trial NCT07398989?
The interventions under investigation include: Cetaphil (DRUG).
Who is sponsoring clinical trial NCT07398989?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07398989 being conducted?
This trial has 2 study locations across California, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photo-aged Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.